Orphazyme names the last day of trading in US
Crisis-struck Orphazyme has set a date for when trading with its American Depositary Shares (ADSs) ceases in the US: Wednesday, July 6.
by marketwire, translated by daniel pedersen
Danish biotech company Orphazyme, which is currently undergoing an in-court restructuring of its organization, reports that trading of its American Depositary Shares (ADSs) will terminate on July 6, a company press release has announced. Secondary trading of these assets ended last Friday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme confirms delisting in the US
For subscribers
Orphazyme files for delisting in US
For subscribers
